Vertus Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 7.25 Cr
as on 02-12-2024
- Paid Up Capital ₹ 6.68 Cr
as on 02-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.25 Cr
as on 02-12-2024
- Satisfied Charges ₹ 4.50 M
as on 02-12-2024
- Revenue %
(FY 2021)
- Profit -226.04%
(FY 2021)
- Ebitda 3.98%
(FY 2021)
- Net Worth -3.64%
(FY 2021)
- Total Assets 27.27%
(FY 2021)
About Vertus Pharma Chem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.25 Cr and a paid-up capital of Rs 6.68 Cr.
The company currently has active open charges totaling ₹18.25 Cr. The company has closed loans amounting to ₹4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nagamani Manne, Naveen Manne, and Vayganti Rao serve as directors at the Company.
- CIN/LLPIN
U24230AP2019PTC111592
- Company No.
111592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vertus Pharma Chem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagamani Manne  | Director | 30-Mar-2019 | Current |
| Naveen Manne | Director | 30-Mar-2019 | Current |
| Vayganti Rao | Director | 06-Jul-2022 | Current |
Financial Performance of Vertus Pharma Chem.
Vertus Pharma Chem Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 226.04% decrease in profit. The company's net worth dipped by a decrease of 3.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vertus Pharma Chem?
In 2021, Vertus Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 08 Sep 2021 | ₹17.85 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Apr 2021 | ₹3.95 M | Open |
Others Creation Date: 27 Dec 2019 | ₹4.50 M | Satisfied |
How Many Employees Work at Vertus Pharma Chem?
Unlock and access historical data on people associated with Vertus Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vertus Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vertus Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
